Pro-Dex, Inc. (PDEX)
62.80
+2.96
(+4.95%)
USD |
NASDAQ |
Sep 11, 16:00
62.59
-0.22
(-0.34%)
After-Hours: 20:00
Pro-Dex Enterprise Value : 209.70M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 209.70M |
| September 10, 2026 | 200.26M |
| September 09, 2026 | 203.00M |
| September 08, 2026 | 221.19M |
| September 04, 2026 | 243.49M |
| September 03, 2026 | 206.34M |
| September 02, 2026 | 208.99M |
| September 01, 2026 | 205.23M |
| August 31, 2026 | 207.46M |
| August 28, 2026 | 208.91M |
| August 27, 2026 | 216.25M |
| August 26, 2026 | 213.00M |
| August 25, 2026 | 217.40M |
| August 24, 2026 | 222.62M |
| August 21, 2026 | 218.83M |
| August 20, 2026 | 220.87M |
| August 19, 2026 | 222.88M |
| August 18, 2026 | 222.72M |
| August 17, 2026 | 223.55M |
| August 14, 2026 | 223.13M |
| August 13, 2026 | 225.94M |
| August 12, 2026 | 224.38M |
| August 11, 2026 | 222.18M |
| August 10, 2026 | 220.70M |
| August 07, 2026 | 218.48M |
| Date | Value |
|---|---|
| August 06, 2026 | 218.23M |
| August 05, 2026 | 220.84M |
| August 04, 2026 | 227.66M |
| August 03, 2026 | 212.27M |
| July 31, 2026 | 196.21M |
| July 30, 2026 | 190.09M |
| July 29, 2026 | 184.45M |
| July 28, 2026 | 189.10M |
| July 27, 2026 | 192.04M |
| July 24, 2026 | 184.61M |
| July 23, 2026 | 183.78M |
| July 22, 2026 | 179.83M |
| July 21, 2026 | 188.05M |
| July 20, 2026 | 183.75M |
| July 17, 2026 | 192.42M |
| July 16, 2026 | 197.83M |
| July 15, 2026 | 189.74M |
| July 14, 2026 | 195.22M |
| July 13, 2026 | 205.70M |
| July 10, 2026 | 209.97M |
| July 09, 2026 | 207.27M |
| July 08, 2026 | 200.03M |
| July 07, 2026 | 197.17M |
| July 06, 2026 | 206.60M |
| July 02, 2026 | 205.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.07B |
| AngioDynamics, Inc. | 593.86M |
| Alphatec Holdings, Inc. | 2.124B |
| AtriCure, Inc. | 2.681B |
| Baxter International, Inc. | 18.98B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.857M |
| Revenue (Quarterly) | 20.40M |
| Total Expenses (Quarterly) | 17.55M |
| EPS Diluted (Quarterly) | 0.8672 |
| Gross Profit Margin (Quarterly) | 34.75% |
| Profit Margin (Quarterly) | 14.00% |
| Earnings Yield | 6.58% |
| Operating Earnings Yield | 6.26% |
| Normalized Earnings Yield | 5.483 |